Introduction
In the past decade, molecular phenotype prediction has increasingly been replacing serologic antigen determination. Systematic donor typing allows to supply units much better matched to the recipient than conventional approaches starting with antigen determination only if there is an acute need for typed units [1, 2] . A large number of methods have been developed that allow high-throughput typing of blood donors for many antigens [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . These methods differ in the antigens predicted, the number of rare alleles covered, and the cost per antigen and per donor. Attempted high-accuracy prediction of a donor's phenotype [3, 11] contrasts with approaches that expect a serologic confirmation on release [8] .
The driving force for large-scale molecular typing differs between populations. In countries with a large number of patients of African descent, the correct identification of 'African' RHCE alleles and Dombrock phenotypes is a major challenge and convincing argument to switch to molecular typing [12, 13] , because serologic typing is unsatisfactory. In some European countries like Germany, such alleles are nearly absent, and compatible units can usually be identified by serologic methods. In these countries, the major challenge is the provision of blood for patients with antibodies to the high-prevalence antigens Kp b , Lu b , Yt a or Vel [14] , and for patients with multiple alloantibodies [15, 16] to the clinical relevant antigens outside ABO and RH. Most of these antigens may be easily determined by serology; hence, any molecular method has to compete with serologic approaches.
A decade ago, we developed a simple multiplex PCR approach that allowed to screen for donors who are negative for high-frequency antigens at less than USD 3.00 per donor [17] . In order to extend this method to the more polymorphic antigens of the Duffy and Kidd blood group system, we adapted our approach to capillary gel electrophoresis with fluorescent dye-labeled sequence-specific primers. Here we present our experience with this improved method.
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Nagel, Düren, Germany). 5 μl of amplificate were analyzed using an ABI 310 capillary sequencer (Thermo-Fisher, Darmstadt, Germany). Applied Biosystems GeneScan 500 LIZ dye size standard (Thermo-Fisher) was used as size marker. Donor-specific antigen status was derived from the ratio of blue and green fluorescence or red and yellow fluorescence (for Lu antigens) at the reaction-and gene-specific product sizes. In our hands, the exact position of the amplicons could differ from the calculated by a few base pairs (bp) and even varied from run to run. Therefore, peak positions calculated by the Gene mapper 4.0 Software were exported to an Excel sheet that included formulas for an advanced identification of the peaks based on the expected peak position and the position of neighboring peaks. In short, for each SNP, first the position of the whole group was identified allowing for a few bp offset, and then within each group the peaks were assigned to the respective samples. Analysis included warnings for low signal intensity, off-scale peaks, and borderline fluorescence ratios. Automated analysis was checked by visual inspection of the electropherograms.
IT Solution for Unit Release
An IT solution to use the obtained data as blood unit sorting algorithm was established: The data were linked to the donor registry. For each donation, it was checked on release whether historical data indicated the probable presence of an useful phenotype (e.g. negative for Kp b or ccD.EE and negative for Fy a and Jk a ). These units were diverted to a 'laboratory inventory' and kept for 1-4 weeks depending on the rarity of the assumed phenotype. If units of this phenotype were demanded, they were confirmed by serology or used without confirmation for preventive matching. If unused, they were rescheduled to general purpose transfusion when the hold phase was finished. 
Sequencing
Sanger sequencing was done using BigDye sequencing kit (Thermo-Fisher). The standard approach for sequencing from genomic DNA was chosen. One or several exons were amplified from genomic DNA and sequenced using the primers also used for amplification or internal sequencing primers. For KEL, the primers of Lee et al. [18] were used.
Statistical Analysis of Mutations in Discrepant Samples
A possible causative role of a polymorphism detected in a sample displaying a discrepant phenotype was evaluated as follows: -Polymorphisms in known null alleles and alleles with destroyed start codon, stop codons in the coding sequence, or frameshift mutations were considered to be causative due to their structure, if a predicted antigen was not present.
-A mutation interfering with primer binding was considered to be causative due to its structure, if the discrepancy was caused by a false-negative antigen prediction. -Polymorphisms known to be highly associated with the polymorphism investigated were considered unlikely to be causing a discrepancy. The only example was c.586G>A in BCAM that is highly associated with the Lu aexpressing LU*01 allele (c.230 G>A) [19] . -The residual samples were counted and the observed mutations evaluated in a sequential manner with correction for multiple testing according to Bonferoni-Holm [20] considering the known allele distribution found in large databases. For each polymorphism observed, its frequency among non-Finnish Europeans was extracted from the ExAC database (exac.broadinstitute.org) [21] . The cumulative frequency of the encountered and all less frequent polymorphisms was calculated. This cumulative frequency was used to calculate the probability that any polymorphism at least as rare was observed among the collated samples (2n alleles) by chance. If the probability was less than 0.01, the polymorphism was considered most likely associated with the discrepant phenotype, if it was less than 0.05, it was considered likely associated or causative. The samples explained by such polymorphism were removed from the set of samples under consideration, and the calculation was repeated with the residual samples until no sample or no polymorphism with likely association was left. 
Hands-On Time and Consumable Cost
Hands-on time and consumable cost were collated and estimated according to the technicians' experience.
Snapshot of Units Available in the Blood Service
Snapshots of the number of available units in our Blood Service were taken from our SAP-based inventory management system (transaction BSD/ MM_Chargenbest).
Results

Antigen Prediction by Pooled Capillary Electrophoresis
A medium-throughput donor typing method was developed based on PCR amplification of crude DNA with fluorescence-labeled allele-specific primers, product length-based barcoding, and analysis by capillary electrophoresis. DNA amplification was performed in two multiplex reactions, one containing primers to predict Co a /Co b , Jk a /Jk b , Lu a /Lu b , and M/N, the other those for Fy a / Fy b , Kp a /Kp b , S/s, and Yt a /Yt b . Each reaction contained sequencespecific primers for both alleles that were 5' labeled with different fluorescence dyes (usually FAM and HEX with the exception of Lu using NED and ROX). Eight variations of these multiplex PCR reactions were developed that yielded PCR products differing by a size of 4 bp from the next shorter version. Thus, eight donor samples were amplified in parallel using eight different versions of the multiplex PCR. All products were pooled, purified, and analyzed in fig. 1) . Obtained fluorescence signals were assigned to sample and polymorphisms according to the product size, and allele status was deduced from the ratio of fluorescences that corresponded to the different alleles. The pooling prior to capillary run increased analysis throughput by a factor of 8. Considering a run time of 50 min, the maximal throughput using a single capillary machine was limited to 230 samples per day. (table 2) , resulting in a set of 4,680 serologic antigen typings. 23 allele pairs could not be predicted in 12 samples due to low signal, in addition 8 antigens were not predicted because of borderline fluorescence ratios in 7 samples. Two samples yielded both failures due to low signal and borderline ratio, resulting in a total of 54 antigens (including 3 Yt b ) that could not predicted in 17 samples, corresponding to a rate of 1.1% failed antigen predictions and 5.4% of samples with at least one failed antigen prediction.
Among the evaluable 4,629 antigen predictions, 4,622 (99.8%) were identical to the serologic result. There were 7 discrepancies: In 5 cases, antigen Fy b was predicted positive, but determined negative by routine serology. These 5 cases were found to be due to the presence of a FY x allele known to express a weak Fy b antigen and considered serologic failures. In one sample, the S antigen was missed in a GYPB*24 allele (Mit-positive allele), because the additional polymorphism in GYPB*24 interfered with primer binding (fig. 2) . Finally, 1 sample was predicted as N-positive but found to be N-negative in serology. Repeat molecular testing yielded the correct prediction, and the discrepancy was categorized as random failure due to technical causes. In conclusion, 4,627 of the 4,629 antigen predictions were correct (99.96%), which corresponded to 98.87% of all antigens attempted to predict.
Hands-On Time and Consumable Cost
Hands-on time and consumable cost was collated (table 3, hands-on time) and compared to a previously developed molecular typing solution based on agarose gel electrophoresis [17] . While the hands-on time per donor for the set-up was slightly lower than in the gel method, visual proofreading of the results incurred an increase of total hand-on time by 49%. Likewise, product cleanseup and capillary electrophoresis was more expensive than agarose gel electrophoresis resulting in a 25% increase of cost per donor. Considering that the capillary electrophoresis yielded 16 predictions, while the gel method only yielded 4, the cost per antigen was about a third of the old method.
Routine Use of Pooled Capillary Electrophoresis
Until December 2017, a total of 136,120 donor samples representative of more than 100,000 donors were tested. The system was modified several times, and Co testing was temporarily dropped to allow the inclusion of other systems. A total of 287 Yt(a-), 145 Co(a-), 96 Lu(b-) and 12 Kp(b-) donors were identified. Data predicted by pooled capillary electrophoresis were pooled with historic serologic data and used to identify units with an 'expected' suitable antigen pattern that were diverted to a special 'laboratory inventory' and kept for 1-4 weeks ( fig. 3 ). The prediction rate was re-evaluated after 34,768 samples (table 4): It dropped to 92.9%, Fy and Yt being the most unstable systems. The main cause of failure was low signal, followed by a borderline fluorescence ratio. Rarely, off-scale peaks (fluorescence too strong for correct color compensation) prevented analysis. For practical purposes, a donor was considered successfully typed if a prediction of Fy a and Fy b was present. From January 1, 2017 to December 31, 2017, a total of 20,861 donor samples were successfully typed, and the 'success rate' was 91% (based on successful Fy typing). During this year, 188,309 (28%) of 670,799 RBC units were from typed donors, 42,731 (23% of typed units, 6% of all units) of these fitted a 'rule' and were stored in the laboratory inventories. This number represents a slight overestimate of the efficiency of the typing project, because some units were selected due to historical serologic typing information. As a result of the computer-controlled guidance of unit use, we were able to maintain a stock of about 10 Lu(b-), 25 Yt(a-) and 15 Co(a-) non-cryoconserved units in our blood service (table 5) . rate of discrepancies cannot be derived from the data, because many units were used for general-purpose transfusion and not checked by serology. Most mispredictions were due to low-quality runs not identified by antigen calling (2017: 65%; all years: 49%) or an attempted manual interpretation of a result that could not be automatically called (2017: 27%; all years: 35%).
Systematic Serologic Typing of Donors Predicted to Be Kp(a+b+), Co(a+b+) or Lu(a+b+)
In order to detect null alleles, samples predicted to be Kp(a+b+), Co(a+b+), or Lu(a+b+) were checked by serology yielding 8 . These numbers compared to 10 Kp(b-), 96 Lu(b-) and 145 Co(a-) donors correctly predicted as Kp(a+b-), Lu(a+-b-) and Co(a-b+), respectively.
Molecular Causes of Discrepant or Weakened Antigen Expression
Rare genotypes detected in donors with discrepant or weakened antigen expression are collated in table 6. Several new alleles with weakened or absent antigen expression were found: 1 for Kell, 2 for Colton, and 8 for Lutheran. Adsorption/elution was done in selected cases only and found to be unreliable: 1 sample with a known KEL mod allele was found negative for Kp a on adsorption/ elution. False-negative predictions due to mutations interfering with primer binding were usually detected during routine use and alleles with weak or absent antigen expression by systematic testing of predicted heterozygotes. 1612A) . In addition, we detected two silent LU*01-derived alleles, and one allele with weak expression of Lu b antigen. No cause could be identified in 3 donors and possibly associated alterations in 2 donors. Most alleles identified in these donors were previously unknown and carried missense mutations, suggesting that they could represent LU mod rather than LU null alleles. Adsorption/elution was done for two alleles only and was positive in one.
For Co a , 2 donors predicted to be Co a /Co b were Co(a-). One carried a mutation in the promoter; in the other one no cause could be identified. In addition, 3 donors had weak or almost absent Co b expression, but a probably causative mutation was found in only 1 of them.
Discussion
We developed a low-cost molecular typing system to screen our donor population for rare antigen constellations. Key features included a simplified DNA isolation approach, simultaneous analysis of several samples by pooled capillary electrophoresis, and the de- known null allele Table 6 . The shown polymorphism are frequent and unlikely to cause the discrepant phenotype. liberate allowance of a relevant failure rate as well as the exclusion of the complicated blood group systems ABO and RH. Implementation of our typing approach on a routine basis resulted in major improvements of RBC supply for patients with anti-Yt a or anti-Lu b .
Continued
Current approaches for high-throughput molecular blood group antigen prediction in blood donors [3] [4] [5] [6] [7] [8] [9] [10] [11] differ relevantly with respect to typing effort, cost, and quality of the results. On one hand, sophisticated approaches attempted a highly reliable determination of the blood type even in many rare phenotypes [3, 11] . Other approaches were optimized for high throughput [8] or low cost [23] and relied on serologic confirmation on release [8, 9] . Our approach may represent the extreme version of low-cost, lowquality testing: we deliberately allowed for a 10% 'no call' rate and did not bother with rare alleles in order to be able to screen a large donor cohort with limited financial resources.
The antigen prediction was focused on the antigens clinically most relevant in our population, excluding ABO, Rh phenotype and K that had to be determined for unit release. Therefore, we complemented predictions for Fy a /Fy b , Jk a /Jk b , S/s, and M/N by a screening approach covering the rare phenotypes most relevant for our population: Kp(b-), Lu(b-), Yt(a-) [14] , and Co(a-). We could not include a prediction of the Vel-phenotype that is caused by a 17 bp deletion [24] , because no information on its molecular basis was available at the start of our typing project. Already in 2008, we showed that molecular typing from crude DNA preparations was useful to screen donors for rare phenotypes. The pooled capillary electrophoresis extended this concept, keeping the simplified DNA isolation method based on the Extract-N-Amp system but replacing agarose gel by capillary electrophoresis. Pooling of 8 samples in a single capillary run resulted in a cost reduction by about 66% and increased throughput by up to 8-fold. In contrast to other donor typing approaches using pooling [25] , product length encoding of the sample number obviated the need for a separate pool resolution. Compared to the agarose gel approach, the number of predicted antigens was quadrupled, resulting in a lower cost per antigen of EUR 0.10 (USD 0.13). The semi-automated analysis of the data allowed the inclusion of all antigen predictions into our donor database and paved the way for an IT-controlled unit guidance system. The simplistic approach came at a cost: the major antigens (evaluated as successful Fy a /Fy b prediction) were successfully predicted in only about 90% of donors (table 4), despite the results being checked manually. Without the manual check, the prediction rate would have been even worse. Furthermore, there was a certain rate of mispredictions resulting in antigen discrepancies on serologic confirmation. These problems often occurred in samples with generally low signals, with technical problems during data interpretation being the main cause of error. Systematic mistyping of alleles was a rarity (table 6) and negligible compared to technical failures; hence we did not perceive it necessary to include additional polymorphisms for antigen prediction. Considering that the observed discrepancies are accumulated from 4 laboratories serving an area with approximately 8 million inhabitants, each laboratory encountered such a problem one to two times a month. Most technicians did not consider this discrepancy rate a practical problem and rather valued the wide availability of units for which a 99% correct antigen status was known.
It should be realized that our approach is critically dependent on the availability of the commercial 'Extract-N-Amp' kit. While there are other enzymes suitable for direct PCR, a change of the DNA isolation and PCR chemistry would incur relevant redesign of the method.
In very rare phenotypes like Kp(b-), compound heterozygotes with one null allele may underlie a relevant proportion of the antigen-negative donors [11] . We tried to verify this proposal by systematic serologic testing of samples predicted to be heterozygous for For Co a , 145 Co(a-) donors found by single polymorphism prediction compared to a single additional Co(a-) donor detected by serologically typing of 1,497 predicted heterozygous donors. A total of 11 previously unknown alleles was found, many of which carried missense mutations suggesting that they may represent mod rather than null alleles. Even if many of them were seen in a single sample only, the statistical significance of the association could usually be proven by a combination of SNP frequency data taken from the ExAC database [21] with a sequential statistical testing approach [20] . For Lu and Co, in a relevant number of samples no cause for the diminished or absent antigen expression was detected, suggesting that regions outside the coding region are of relevance for Co and Lu expression. While serologic typing of predicted heterozygous donors was an interesting tool to find possible null alleles, it had minor impact on the number of identified antigen-negative donors.
Our large-scale typing program was complemented by an IT solution that allowed to select suitable donors and to guide units with predicted interesting phenotypes into the 'laboratory inventory' by a check of the predicted antigen pattern to a set of 'rules'. The importance of a suitable IT integration of the typing process has been stressed by Perreault et al. [26] and becomes obvious considering the number of available k-units: For many years before the start of the project, RhD-K+ donors were systematically tested for antigen k, but without a working IT solution, we were unable to establish a stock useful in emergency situations.
In conclusion, our strategy allowed us to apply this approach to 20% of our RBC units (i.e. more than 120,000 units/year) and obviated the need for several rounds of serologic antigen screening when a patient with multiple antibodies needed blood: For a patient needing 4 Jk(a-) Fy(a-) units, in older times 64 units were tested for Jk RBC units can now be fulfilled in the majority of cases. The typing project thus decisively improved the transfusion support for alloimmunized patients.
